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Purpose
Assess the beneficial and harmful effects of herbal medi-
cines on Fatty Liver Disease (FLD).
Methods
We searched for randomised clinical trials comparing her-
bal medicine with placebo, no treatment, lifestyle therapy
or western interventions in participants with FLD in The
Cochrane Hepato-Biliary Group Controlled Trials Regis-
ter, The Cochrane Library, MEDLINE, EMBASE, Science
Citation Index Expanded till May 2011, Chinese BioMedi-
cal Database, Traditional Chinese Medical Literature Ana-
lysis and Retrieval System, China National Knowledge
Infrastructure, Chinese VIP Information, Chinese Aca-
demic Conference Papers Database, Chinese Dissertation
Database, and Allied and Complementary Medicine Data-
base till June 2011. We used risk of bias to assess trial
methodological quality. The effects estimates were pre-
sented as relative risks (RR) with 95% confidence intervals
(CI) or as mean differences (MD) with 95% CI depending
on variables of the outcome measures.
Results
We included 25 randomised trials which involving 2257
FLD participants. The mean sample size was 90.3 partici-
pants (ranging from 40 to 146 participants per trial). Risk
of bias of the included trials was high or unclear. Twenty-
three different herbal medicines were tested in the RCTs.
None of the trials reported death, hepatic-related morbid-
ity, quality of life or cost. Surrogate outcomes such as
s e r u mA S T ,A L T ,G G T ,A L P ,Bu l t r a s o u n df i n d i n g s ,C T
scan findings and adverse effects were reported. Qinyin
tea and Danning tablet did not show beneficent effects on
outcomes of ALT, AST, B ultrasound and ALP. Qinyin
capsule did not show beneficial significant effect on ALT
(MD 17.80, 95% CI 6.35 to 29.25). Other herbal medicines
showed beneficial effect on at least one of the reported
biochemical outcomes. No serious adverse events were
reported.
Conclusion
Some herbal medicines may have potential effects on
FLD and they appear safe to use. The findings are not
confirmatory due to high or unclear risk of bias of the
included trials and limited number of trials on indivi-
dual herbal medicines.
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